Phenex Pharmaceuticals AG
PrivateLast Round
M&A
Jan 6, 2015
Total Funding Raised
$26.2M
Company Overview
Phenex Pharmaceuticals AG is a biotechnology company that specializes in the discovery and development of small-molecule drugs for liver, gastrointestinal, and cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phenex Pharmaceuticals AG Comparables
Compare Phenex Pharmaceuticals AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lead Pharma | 84% | |
| Orphagen Pharmaceuticals | 83% | |
| WMT AG | 78% |
Phenex Pharmaceuticals AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jan 6, 2015 | ||||
| VC Round | Oct 1, 2012 | ||||
| Series C | Sep 21, 2010 | ||||
| Grant | Jul 1, 2009 | ||||
| Series B | Oct 2, 2008 | ||||
Series A | Oct 11, 2005 |
Phenex Pharmaceuticals AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| equinet Bank | Series A |
| CD-Venture | Series C |
| Creathor Venture | Series C, Series B |
| KfW Development Bank | Series B, Series C, Series A |
| LBBW Venture Capital | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2015
$470M round led by Gilead Sciences
- Oct 1, 2012
Raised $6.5M in a VC Round.
Phenex Pharmaceuticals AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Phenex Pharmaceuticals AG's valuation, stock price, and market status.
Is Phenex Pharmaceuticals AG a public or private company?
Phenex Pharmaceuticals AG is a private company.
What is the current stock price of Phenex Pharmaceuticals AG?
Phenex Pharmaceuticals AG is a private company, so its shares have no public market price. Caplight tracks Phenex Pharmaceuticals AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phenex Pharmaceuticals AG worth (valuation)?
Valuation information for Phenex Pharmaceuticals AG is not publicly available.
Can I buy Phenex Pharmaceuticals AG stock?
Phenex Pharmaceuticals AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phenex Pharmaceuticals AG's last funding round?
Phenex Pharmaceuticals AG's most recent funding round was M&A on January 6, 2015.
Who are the main investors in Phenex Pharmaceuticals AG?
Key investors in Phenex Pharmaceuticals AG include Creathor Venture.
Will Phenex Pharmaceuticals AG IPO soon?
No public IPO plans have been announced for Phenex Pharmaceuticals AG.
How can I track Phenex Pharmaceuticals AG secondary market activity?
Caplight tracks bids, offers, and trades in Phenex Pharmaceuticals AG's shares on secondary markets.